U.S. flag

An official website of the United States government

NM_014946.4(SPAST):c.1196C>G (p.Ser399Trp) AND Hereditary spastic paraplegia 4

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 24, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000536355.7

Allele description [Variation Report for NM_014946.4(SPAST):c.1196C>G (p.Ser399Trp)]

NM_014946.4(SPAST):c.1196C>G (p.Ser399Trp)

Gene:
SPAST:spastin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p22.3
Genomic location:
Preferred name:
NM_014946.4(SPAST):c.1196C>G (p.Ser399Trp)
HGVS:
  • NC_000002.12:g.32128430C>G
  • NG_008730.1:g.69820C>G
  • NM_001363823.2:c.1193C>G
  • NM_001363875.2:c.1097C>G
  • NM_001377959.1:c.1100C>G
  • NM_014946.4:c.1196C>GMANE SELECT
  • NM_199436.2:c.1100C>G
  • NP_001350752.1:p.Ser398Trp
  • NP_001350804.1:p.Ser366Trp
  • NP_001364888.1:p.Ser367Trp
  • NP_055761.2:p.Ser399Trp
  • NP_055761.2:p.Ser399Trp
  • NP_955468.1:p.Ser367Trp
  • LRG_714t1:c.1196C>G
  • LRG_714:g.69820C>G
  • LRG_714p1:p.Ser399Trp
  • NC_000002.11:g.32353499C>G
  • NM_014946.3:c.1196C>G
Protein change:
S366W
Links:
dbSNP: rs1553317025
NCBI 1000 Genomes Browser:
rs1553317025
Molecular consequence:
  • NM_001363823.2:c.1193C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363875.2:c.1097C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377959.1:c.1100C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014946.4:c.1196C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_199436.2:c.1100C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary spastic paraplegia 4
Synonyms:
Spastic paraplegia 4, autosomal dominant; Familial spastic paraplegia autosomal dominant 2
Identifiers:
MONDO: MONDO:0008438; MedGen: C1866855; Orphanet: 100985; OMIM: 182601

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000645341Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 24, 2024)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

[Identification of SPAST gene variant in a pedigree affected with hereditary spastic paraplegia type 4].

Qi N, Ma M, Yang K, Lou G, Qin L, Hou Q, Zhang Y, Liao S.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Nov 10;37(11):1261-1264. doi: 10.3760/cma.j.cn511374-20191120-00592. Chinese.

PubMed [citation]
PMID:
33179235

Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia.

Meijer IA, Hand CK, Cossette P, Figlewicz DA, Rouleau GA.

Arch Neurol. 2002 Feb;59(2):281-6.

PubMed [citation]
PMID:
11843700
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000645341.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces serine, which is neutral and polar, with tryptophan, which is neutral and slightly polar, at codon 399 of the SPAST protein (p.Ser399Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary spastic paraplegia (PMID: 33179235; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 468561). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SPAST protein function with a positive predictive value of 80%. This variant disrupts the p.Ser399 amino acid residue in SPAST. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11843700, 16832076, 19875132, 22960362, 29980238). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024